PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS

被引：0
|
作者：
Wu, Jing [1 ]
Bryla, Christine [1 ]
Su, Yu-Ting [1 ]
Grajkowska, Ewa [1 ]
McCoy, Ann [2 ]
Boris, Lisa [1 ]
Antony, Ramya [1 ]
Garren, Nancy [2 ]
Siegel, Christine [1 ]
Cordova, Christine [1 ]
Aboud, Orwa [1 ]
Vera, Elizabeth [1 ]
Lawhon, Tracy [3 ]
Penas-Prado, Marta [1 ]
Theeler, Brett [1 ]
Mendoza, Tito [4 ]
Armstrong, Terri [1 ]
Yuan, Ying [4 ]
Gilbert, Mark [1 ]
机构：
[1] NCI, Neurooncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Bethesda, MD 20892 USA
[3] Adastra Pharmaceut Inc, San Diego, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-62
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [31] Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
    Wu, Jing
    Yuan, Ying
    Priel, Debra A. Long
    Fink, Danielle
    Peer, Cody J.
    Sissung, Tristan M.
    Su, Yu-Ting
    Pang, Ying
    Yu, Guangyang
    Butler, Madison K.
    Mendoza, Tito R.
    Vera, Elizabeth
    Ahmad, Salman
    Bryla, Christine
    Lindsley, Matthew
    Grajkowska, Ewa
    Mentges, Kelly
    Boris, Lisa
    Antony, Ramya
    Garren, Nancy
    Siegel, Christine
    Lollo, Nicole
    Cordova, Christine
    Aboud, Orwa
    Theeler, Brett J.
    Burton, Eric M.
    Penas-Prado, Marta
    Leeper, Heather
    Gonzales, Javier
    Armstrong, Terri S.
    Calvo, Katherine R.
    Figg, William D.
    Kuhns, Douglas B.
    Gallin, John, I
    Gilbert, Mark R.
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3298 - 3306
  • [32] A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas
    Vasilios Karavasilis
    Vassiliki Kotoula
    George Pentheroudakis
    Despina Televantou
    Sofia Lambaki
    Sofia Chrisafi
    Mattheos Bobos
    George Fountzilas
    Journal of Neurology, 2013, 260 : 1469 - 1480
  • [33] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2009, 11 (06) : 906 - 906
  • [34] Carboplatin plus paclitaxel weekly dose-dense chemotherapy for high-grade ovarian cancer: A re-evaluation
    Kessous, Roy
    Matanes, Emad
    Laskov, Ido
    Wainstock, Tamar
    Abitbol, Jeremie
    Yasmeen, Amber
    Salvador, Shannon
    Lau, Susie
    Gotlieb, Walter H.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2021, 100 (03) : 453 - 458
  • [35] A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood
    Jakacki, Regina I.
    Yates, Allan
    Blaney, Susan M.
    Zhou, Tianni
    Timmerman, Robert
    Ingle, Ashish M.
    Flom, Lynda
    Prados, Michael D.
    Adamson, Peter C.
    Pollack, Ian F.
    NEURO-ONCOLOGY, 2008, 10 (04) : 569 - 576
  • [36] A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: PATIENT REPORTED OUTCOMES(PRO) FROM A CERN CLINICAL TRIAL
    Armstrong, Terri S.
    Vera-Bolanos, Elizabeth
    Gilbert, Mark
    Yuan, Ying
    Wani, Khalida
    Wu, Jimin
    Omuro, Antonio
    Lieberman, Frank
    Robins, H. Ian
    Gerstner, Elizabeth
    Wu, Jing
    Wen, Patrick
    Mikkelsen, Tom
    Aldape, Ken
    Mendoza, Tito
    NEURO-ONCOLOGY, 2014, 16
  • [37] Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma
    Neyns, B.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Sadones, J.
    Nupponen, N. N.
    Michotte, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
    Mark R. Gilbert
    Stephanie L. Pugh
    Ken Aldape
    A. Gregory Sorensen
    Tom Mikkelsen
    Marta Penas-Prado
    Felix Bokstein
    Young Kwok
    R. Jeffrey Lee
    Minesh Mehta
    Journal of Neuro-Oncology, 2017, 131 : 193 - 199
  • [39] NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
    Gilbert, Mark R.
    Pugh, Stephanie L.
    Aldape, Ken
    Sorensen, A. Gregory
    Mikkelsen, Tom
    Penas-Prado, Marta
    Bokstein, Felix
    Kwok, Young
    Lee, R. Jeffrey
    Mehta, Minesh
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) : 193 - 199
  • [40] Phase II trial of functional imaging-optimized stereotactic fractionated radiotherapy plus temozolomide for recurrent high-grade glioma.
    Nieder, C
    Wiedenmann, N
    Stark, S
    Grosu, AL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 120S - 120S
12345